News
Sales up 18pc, profits up 32pc — yet Ozempic maker Novo Nordisk feels the weight of US competition
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit today, but rising competition is ...
Novo Nordisk A/S’s sales showed the weakest growth in four years as the Danish drugmaker loses ground to Eli Lilly & Co. in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback